Member Info for Formul1187

wow

they were yesterdays buys

correct me if im wrong looks like late reported buys from yesterday ?

Signal UpdateOur system’s recommendation today is to BUY. The BULLISH HARAMI CROSS pattern finally received a confirmation because the prices crossed above the confirmation level which was at 8.8000, and our valid average buying price stands now at 8.8800. The previous SELL signal was issued on 22/02/2021, 15 days ago, when the stock price was 10.3150. Since then N4P.L has fallen by -13.91%.Market OutlookLet’s jump on our white horses and go for a bullish ride. The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated. The market is telling you about a new profit. Do not miss this bullish opportunity

Maybe some late reported buys after trading hours , this will gap us up on open following day, let’s see

Chunky buys coming through well done holders

Strong bottom gone new highs

I have been saying, well the bottoms gone now, aiming for new highs

https://mobile.twitter.com/hashtag/n4p?f=live

Bulls sitting watching

Outlook The market is finally giving hints of a bullish resurgence. Today a bullish pattern is detected

Little sudden tree shake like clockwork before news dyor

Expecting a fall in share price tomorrow buckle up

Recent media coverage bodes well, we are on the watch now

Did the same with sng now sitting on a life changing amount of profit, I’m also heavy in n4p which also is a sleeping giant like fum

Lol I have topped up lots at 8.5p, also in at various levels, I’m still here staying, the journey to success has just started again

I am new on this Board but have been building my stake in FUM over the last year/half and watched/waited. I have worked in Pharma for the last 20 years and this deal is a good one for them. The partner takes all the risk, pays the development and marketing and FUM will just provide technical advice and support so no real costs for them. And they take 50%. I expect a licesnsing deal for the US rights to be a bit more typical - so a small upfront, partner pays for the final FDA trial and FUM take double digit tiered royalties. In Europe, I can see them doing a similar JV deal as they can contribute more, This deal will wake up the major pharma players. Remember Ken James is ex GSK. DYOR but this looks like a great pathway for MED3000. And then you get the cannabaloid gel thrown in for nothing.

Definitely on the cards

https://mobile.twitter.com/hashtag/fum?f=live

If the post are removed, she really did tip us of that’s how I see it